Ignite Creation Date:
2024-05-06 @ 7:51 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06162286
Status:
RECRUITING
Last Update Posted:
2024-06-14
First Post:
2023-11-30
Brief Title:
A Phase 3b Randomized Double-blind Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP
Sponsor:
Zai Lab Hong Kong Ltd
Organization:
Zai Lab Hong Kong Ltd
Organization Data
Organization:
Zai Lab Hong Kong Ltd
Class:
INDUSTRY
Study ID:
ZL-2401-004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Zai Lab Hong Kong Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None